ORCID Profile
0000-0002-4826-1475
Current Organisation
World Health Organization
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Springer Science and Business Media LLC
Date: 17-09-2012
Publisher: Springer Science and Business Media LLC
Date: 11-09-2015
Publisher: BMJ
Date: 06-2019
DOI: 10.1136/BMJOPEN-2018-024449
Abstract: Maternal immunization (MI) with tetanus toxoid containing vaccine, is a safe and cost-effective way of preventing neonatal tetanus. Given the prospect of introducing new maternal vaccines in the near future, it is essential to identify and understand current policies, practices and unmet needs for introducing and/or scaling up MI in low-income and middle-income countries (LMICs). The Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) is a mixed methods, cross-sectional study that will collect data in four phases: (1) a review of global databases for selected health indicators in 136 LMICs (2) a structured online survey directed at Maternal, Newborn and Child Health and Expanded Programme on Immunization focal points in all 136 LMICs (3) semistructured telephone interviews of 30 selected LMICs and (4) 10 week-long country visits, including key informant interviews, health facility visits and focus group discussions. The principal analyses will assess correlations between the various aspects of MI delivery strategies and proxy measures of health systems performance related to vaccine-preventable disease control. The primary outcome will be a typology of existing MI delivery models, and secondary outcomes will include country profiles of child and maternal health indicators, and a MI gaps and needs analysis. The protocol was approved by the WHO Ethics Review Committee (ERC.0002908). The results will be made available in a project report and submitted for publication in peer-reviewed journals that will be shared broadly among global health decision-makers, researchers, product developers and country-level stakeholders.
Publisher: Springer Science and Business Media LLC
Date: 12-2011
Publisher: Springer Science and Business Media LLC
Date: 17-11-2009
Publisher: Elsevier BV
Date: 07-2020
Publisher: Elsevier BV
Date: 2020
Publisher: Springer Science and Business Media LLC
Date: 26-01-2012
Publisher: Elsevier BV
Date: 04-2018
Publisher: Springer Science and Business Media LLC
Date: 09-06-2011
Publisher: Elsevier BV
Date: 07-2020
Publisher: Wiley
Date: 24-09-2010
DOI: 10.1111/J.1471-0528.2010.02714.X
Abstract: In Bangladesh, the majority of women give birth at home. There is anecdotal evidence that unqualified allopathic practitioners (UAPs) administer oxytocin at home births to augment labour pain. The objective is to explore the use of oxytocin to augment labour pain during home births in an urban slum in Dhaka, Bangladesh. Cross-sectional survey. KamrangirChar slum, Dhaka, Bangladesh. Married women with a home birth or who experienced labour at home in the 6 months prior to the survey (n = 463) were interviewed. Twenty-seven UAPs were interviewed to validate women's responses. Bivariate and multivariate logistic regressions were used to identify significant predictors of oxytocin use. Reported use of oxytocin to augment labour pain. Forty-six percent of women reported using medicine or other treatments to augment labour pain, 131 of whom reported using oxytocin (28% of total). Traditional birth attendants were the predominant decision-makers of when to use oxytocin. The medication was provided by a UAP who administered the drug via saline infusion or intramuscular injection. Higher education, lower parity, reported long labour (more than 12 hours), and knowledge of and positive attitudes towards oxytocin were significantly associated with oxytocin use after controlling for other factors. In the validation exercise, there was agreement about the use of oxytocin to augment labour in 22 of 27 cases (82%). About one-third of women used oxytocin to augment labour pain. This practice has implications for health education as well as future research to assess the impact on adverse maternal and neonatal outcomes.
Publisher: Wiley
Date: 20-08-2008
Location: Bangladesh
Location: United States of America
Location: United States of America
Location: No location found
Location: No location found
No related grants have been discovered for Allisyn C Moran.